Showing results (31-40 of 204) with videos related to
Sort By:
Pageof 21
Respiratory Medicine|March 8, 2011
Evaluation of exhaled breath condensate pH as a biomarker for COPDWilliam MacNee, Stephen I Rennard, John F Hunt, et al.Respiratory Research|June 14, 2020
CXCR2 antagonist for patients with chronic obstructive pulmonary disease with chronic mucus hypersecretion: a phase 2b trialAili L Lazaar, Bruce E Miller, Alison C Donald, et al.Respiratory Medicine|July 29, 2018
Distribution, temporal stability and association with all-cause mortality of the 2017 GOLD groups in the ECLIPSE cohortRosa Faner, Guillaume Noell, Joan Ramon Badia, et al.Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|September 22, 2012
Safety and early treatment effects of the CXCR2 antagonist SB-656933 in patients with cystic fibrosisRichard B Moss, Sunil J Mistry, Michael W Konstan, et al.Journal of Patient Experience|February 6, 2023
The COPD Foundation's COPD360Net Initiative Approach to Patient-Centric Drug Development: A Case Study in Using Patient Surveys to Inform New Treatments for Viral Respiratory InfectionsRuth Tal-Singer, Bruce E Miller, Jean M Rommes, et al.Chronic Respiratory Disease|January 17, 2018
Frailty: A global measure of the multisystem impact of COPDNichola S Gale, Ali M Albarrati, Margaret M Munnery, et al.Journal of Clinical Pharmacology|November 18, 2011
An oral inhibitor of p38 MAP kinase reduces plasma fibrinogen in patients with chronic obstructive pulmonary diseaseDavid A Lomas, David A Lipson, Bruce E Miller, et al.Respiratory Research|July 21, 2019
DSP variants may be associated with longitudinal change in quantitative emphysemaWoori Kim, Michael H Cho, Phuwanat Sakornsakolpat, et al.Pharmacology Research & Perspectives|February 19, 2015
Gene expression changes caused by the p38 MAPK inhibitor dilmapimod in COPD patients: analysis of blood and sputum samples from a randomized, placebo-controlled clinical trialJoanna C Betts, Ruth J Mayer, Ruth Tal-Singer, et al.COPD|March 14, 2012
p38 mitogen-activated protein kinase is not activated in the quadriceps of patients with stable chronic obstructive pulmonary diseaseJoanna Riddoch-Contreras, Tomasz George, Samantha A Natanek, et al.Pageof 21